NCT06095635

Brief Summary

Introduction: Most cardiovascular diseases (CVD) can be prevented and controlled by adopting lifestyle changes, such as regular physical exercise and nutrition. Resveratrol and beverage extract promote beneficial health effects due to their nutritional properties. Objective: to analyze the effects of resveratrol supplementation and withdrawal extract on post-exercise recovery in coronary heart disease patients. Methods: men diagnosed with ischemic coronary artery disease will undergo four exercise protocols consisting of 30 minutes of aerobic exercise on an ergometric treadmill, with 5 minutes of warm-up, intensity of 30% of the heart rate reserve (HRR), followed by 25 minutes at intensity 60% of FCR and for a final 30 minutes of recovery in the supine position. Before each exercise protocol, all volunteers will consume: 500 mg of placebo (starch), or 500 mg of beetroot, or 500 mg of resveratrol and will also consume resveratrol and drink (500 mg each) 30 minutes before exercise. , the order of each supplementation will be done randomly. Cardiorespiratory parameters and heart rate variability (HRV) will be assessed at different times throughout the experimental procedure. To analyze the moments (rest versus recovery), the Bonferroni post-test will be used for parametric distribution or the Dunn post-test for non-parametric distribution. Statistical significance will be calculated at 5% for all analyses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

October 4, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

October 4, 2023

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Heart rate variability (HRV)

    Time and frequency domain of HRV

    through study completion, an average of 1 hour

Secondary Outcomes (1)

  • Blood Pressure

    through study completion, an average of 1 hour

Study Arms (4)

Placebo Protocol

PLACEBO COMPARATOR

exercise and placebo capsules 500 mg (starch)

Other: Placebo Protocol

Protocol Beet

EXPERIMENTAL

exercise and beet extract 500 mg

Other: Protocol Beet

Protocol Resveratrol

EXPERIMENTAL

exercise and resveratrol capsules 500 mg

Other: Protocol Resveratrol

Protocol Beet and Resveratrol

EXPERIMENTAL

exercise and beet extract 500mg and resveratrol capsules 500 mg

Other: Protocol Beet and Resveratrol

Interventions

ingestion of 500 mg of starch following 30 minutes of exercise (treadmill)

Also known as: 500 mg of starch
Placebo Protocol

ingestion of 500 mg of beet extect following 30 minutes of exercise (treadmill)

Also known as: 500 mg of beet extract
Protocol Beet

ingestion of 500 mg of resveratrol following 30 minutes of exercise (treadmill)

Also known as: 500 mg of resveratrol
Protocol Resveratrol

ingestion 500 mg of beet extect and 500 mg of resveratrol following 30 minutes of exercise (treadmill)

Also known as: 500 mg of beet extect and 500 mg of resveratrol
Protocol Beet and Resveratrol

Eligibility Criteria

Age40 Years - 79 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult men over 45 years of age
  • diagnosed with ischemic coronary artery disease and with preserved left ventricular function (above 50%), confirmed by a previous echocardiogram

You may not qualify if:

  • Volunteers who present at least one of the following characteristics will be excluded:
  • smokers
  • alcohol drinkers
  • those who did not attend a cardiovascular rehabilitation program for at least 3 months prior to data collection
  • individuals who have known infections, metabolic and respiratory diseases that could interfere in cardiac autonomic control, unstable angina, uncontrolled hypertension, significant valvular disease, uncontrolled metabolic disease (e.g., uncontrolled diabetes and thyroid disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Estadual Paulista

Presidente Prudente, São Paulo, 19060-900, Brazil

Location

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

StarchSucroseResveratrol

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

GlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesPolysaccharidesDisaccharidesOligosaccharidesSugarsStilbestrolsStilbenesBenzylidene CompoundsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolyphenolsPhenols

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 4, 2023

First Posted

October 23, 2023

Study Start

March 10, 2022

Primary Completion

January 10, 2023

Study Completion

September 30, 2023

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations